ibrutinib,obinutuzumab,venetoclax
roche,abbvie
['leukemia', 'a041702']
results at #asco23 on trial a041702: results of a phase 3 study of ivo vs io for previously untreated older patients with chronic lymphocytic leukemia and impact of covid-19 , in oral abstract session, 9:45 - 9:57am cdt, on june 6th! more: 
Official Twitter account of NCI's Cancer Therapy Evaluation Program, providing updates to our trials research community. Part of @NIH. Privacy: https://t.co/9Aox3geiD8